一种评估缺失数据假设中潜在违规敏感性的引爆点方法。

IF 1.3 4区 医学 Q4 PHARMACOLOGY & PHARMACY
Cesar Torres, Gregory Levin, Daniel Rubin, William Koh, Rebecca Chiu, Thomas Permutt
{"title":"一种评估缺失数据假设中潜在违规敏感性的引爆点方法。","authors":"Cesar Torres, Gregory Levin, Daniel Rubin, William Koh, Rebecca Chiu, Thomas Permutt","doi":"10.1002/pst.70002","DOIUrl":null,"url":null,"abstract":"<p><p>It is critical to evaluate the sensitivity of conclusions from a clinical trial to potential violations in the missing data assumptions of the statistical analysis. Sensitivity analyses should not consist of a few methods that might have been reasonable alternatives to the chosen analysis method, nor should they explore only a limited space of violations in the assumptions of the analysis. Instead, sensitivity analyses should target the same estimand as that targeted in the main analysis, and they should systematically and comprehensively explore the space of possible assumptions to evaluate whether the key conclusions hold up under all plausible scenarios. In a randomized, controlled trial, this can be achieved by tipping point analyses that vary assumptions about missing outcomes on the experimental and control arms to identify and discuss the plausibility of scenarios under which there is no longer evidence of a treatment effect. We introduce a simple, novel tipping point approach in which, for a variable that is quantitative or can be analyzed as if it is quantitative, inference on the treatment effect is based on the observed data and two sensitivity parameters, with minimal assumptions and no need for imputation. The sensitivity parameters to be varied are the mean differences between outcomes in dropouts and outcomes in completers on each of the two treatment arms. We derive the asymptotic properties of the proposed statistic and illustrate the utility of such an approach with two examples of drug reviews in which the methodology was utilized to inform regulatory decision-making.</p>","PeriodicalId":19934,"journal":{"name":"Pharmaceutical Statistics","volume":"24 3","pages":"e70002"},"PeriodicalIF":1.3000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions.\",\"authors\":\"Cesar Torres, Gregory Levin, Daniel Rubin, William Koh, Rebecca Chiu, Thomas Permutt\",\"doi\":\"10.1002/pst.70002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>It is critical to evaluate the sensitivity of conclusions from a clinical trial to potential violations in the missing data assumptions of the statistical analysis. Sensitivity analyses should not consist of a few methods that might have been reasonable alternatives to the chosen analysis method, nor should they explore only a limited space of violations in the assumptions of the analysis. Instead, sensitivity analyses should target the same estimand as that targeted in the main analysis, and they should systematically and comprehensively explore the space of possible assumptions to evaluate whether the key conclusions hold up under all plausible scenarios. In a randomized, controlled trial, this can be achieved by tipping point analyses that vary assumptions about missing outcomes on the experimental and control arms to identify and discuss the plausibility of scenarios under which there is no longer evidence of a treatment effect. We introduce a simple, novel tipping point approach in which, for a variable that is quantitative or can be analyzed as if it is quantitative, inference on the treatment effect is based on the observed data and two sensitivity parameters, with minimal assumptions and no need for imputation. The sensitivity parameters to be varied are the mean differences between outcomes in dropouts and outcomes in completers on each of the two treatment arms. We derive the asymptotic properties of the proposed statistic and illustrate the utility of such an approach with two examples of drug reviews in which the methodology was utilized to inform regulatory decision-making.</p>\",\"PeriodicalId\":19934,\"journal\":{\"name\":\"Pharmaceutical Statistics\",\"volume\":\"24 3\",\"pages\":\"e70002\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmaceutical Statistics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/pst.70002\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Statistics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/pst.70002","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

评估临床试验结论对统计分析中缺失数据假设中潜在违规行为的敏感性是至关重要的。敏感性分析不应由几种可能是所选分析方法的合理替代方法组成,也不应只探索分析假设中有限的违规空间。相反,敏感性分析的目标应该与主要分析的目标相同,它们应该系统地、全面地探索可能的假设空间,以评估关键结论是否在所有可能的情况下都成立。在一项随机对照试验中,这可以通过临界点分析来实现,该分析改变了对实验和对照组缺失结果的假设,以确定和讨论不再有证据表明治疗效果的情景的可行性。我们引入了一种简单、新颖的临界点方法,其中,对于定量变量或可以像定量一样分析的变量,对治疗效果的推断是基于观察到的数据和两个灵敏度参数,假设最少,不需要imputation。要改变的敏感性参数是两个治疗组中每个治疗组中退出组和完成组结果之间的平均差异。我们推导了所提出的统计量的渐近性质,并通过两个药物审查的例子说明了这种方法的实用性,其中该方法被用于通知监管决策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions.

It is critical to evaluate the sensitivity of conclusions from a clinical trial to potential violations in the missing data assumptions of the statistical analysis. Sensitivity analyses should not consist of a few methods that might have been reasonable alternatives to the chosen analysis method, nor should they explore only a limited space of violations in the assumptions of the analysis. Instead, sensitivity analyses should target the same estimand as that targeted in the main analysis, and they should systematically and comprehensively explore the space of possible assumptions to evaluate whether the key conclusions hold up under all plausible scenarios. In a randomized, controlled trial, this can be achieved by tipping point analyses that vary assumptions about missing outcomes on the experimental and control arms to identify and discuss the plausibility of scenarios under which there is no longer evidence of a treatment effect. We introduce a simple, novel tipping point approach in which, for a variable that is quantitative or can be analyzed as if it is quantitative, inference on the treatment effect is based on the observed data and two sensitivity parameters, with minimal assumptions and no need for imputation. The sensitivity parameters to be varied are the mean differences between outcomes in dropouts and outcomes in completers on each of the two treatment arms. We derive the asymptotic properties of the proposed statistic and illustrate the utility of such an approach with two examples of drug reviews in which the methodology was utilized to inform regulatory decision-making.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Pharmaceutical Statistics
Pharmaceutical Statistics 医学-统计学与概率论
CiteScore
2.70
自引率
6.70%
发文量
90
审稿时长
6-12 weeks
期刊介绍: Pharmaceutical Statistics is an industry-led initiative, tackling real problems in statistical applications. The Journal publishes papers that share experiences in the practical application of statistics within the pharmaceutical industry. It covers all aspects of pharmaceutical statistical applications from discovery, through pre-clinical development, clinical development, post-marketing surveillance, consumer health, production, epidemiology, and health economics. The Journal is both international and multidisciplinary. It includes high quality practical papers, case studies and review papers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信